Skip to main content

and
  1. No Access

    Article

    Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma

    Rapid development of drug resistance after chemotherapy is a major cause of treatment failure in individuals with pancreatic ductal adenocarcinoma (PDAC). In this study, we illustrate that tumor-derived interl...

    Huizhi Sun, Yi Ge, **g Liu, Zengxun Li, Hui Li, Tiansuo Zhao, **uchao Wang in Oncogene (2024)

  2. Article

    Open Access

    Correction: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    VEGF inhibitors are one of the most successful antiangiogenic drugs in the treatment of many solid tumors. Nevertheless, pancreatic adenocarcinoma (PAAD) cells can reinstate tumor angiogenesis via activation o...

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

    Chemoresistance is the main reason for the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Thus, there is an urgent need to screen out new targets and compounds to reverse chemotherapeutic resistance.

    Tianxing Zhou, Yongjie **e, Xupeng Hou in Journal of Experimental & Clinical Cancer … (2023)

  5. Article

    Open Access

    ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis

    Desmoplastic stroma, a feature of pancreatic ductal adenocarcinoma (PDAC), contains abundant activated pancreatic stellate cells (PSCs). How PSCs promote PDAC progression remains incompletely understood.

    Tiansuo Zhao, Di **ao, Fanjie **, Xugang Sun, Jie Yu in British Journal of Cancer (2022)

  6. Article

    Open Access

    Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression

    Interleukin 35 (IL-35) is a novel member of the IL-12 family, consisting of an EBV-induced gene 3 (EBI3) subunit and a P35 subunit. IL-35 is an immune-suppressive cytokine mainly produced by regulatory T cells...

    Chongbiao Huang, Na Li, Zengxun Li, Antao Chang, Yanan Chen in Nature Communications (2017)

  7. No Access

    Article

    Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells

    This study aimed to investigate the expression of Wnt2 protein in pancreatic cancer tissues and pancreatic stellate cells (PSCs), and determine its effect on the biological functions of pancreatic cancer cells...

    Yong Xu, Hua Li, Chongbiao Huang, Tiansuo Zhao, Huan Zhang, Chen Zheng in Medical Oncology (2015)

  8. Article

    Retraction Note to: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2

    Zhenguo Song, He Ren, Song Gao, Tiansuo Zhao, **uchao Wang in Medical Oncology (2015)

  9. No Access

    Article

    RETRACTED ARTICLE: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2

    This study aimed to investigate the interaction and regulatory mechanism of microRNA185 (miR185) and hypoxia-inducible factor-1 (HIF-1) in pancreatic cancer. The significance of miR185 on the clinicopathologic...

    Zhenguo Song, He Ren, Song Gao, Tiansuo Zhao, **uchao Wang in Medical Oncology (2013)